Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Revenue
Noevir Holdings Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Revenue
¥63B
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
Shiseido Co Ltd
TSE:4911
|
Revenue
¥973B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Revenue
¥263.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Revenue
¥173.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
Kao Corp
TSE:4452
|
Revenue
¥1.5T
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Revenue
¥173.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
See Also
What is Noevir Holdings Co Ltd's Revenue?
Revenue
63B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Revenue amounts to 63B JPY.
What is Noevir Holdings Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
3%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Noevir Holdings Co Ltd have been 8% over the past three years , 1% over the past five years , and 3% over the past ten years .